CLINICAL_TRIALS
trial_result
· 2019-10-31
Clinical Trial Update: Phase II Study of GIVINOSTAT (ITF2357) in Combination With Hydroxyurea in Polycythemia Vera [Phase 2]
Summary
Phase II study of GIVINOSTAT (ITF2357) in combination with hydroxyurea in polycythemia vera has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Italfarmaco | Conditions: Polycythemia Vera | Phase 2 | Status: COMPLETED | Results posted: 2019-10-31